Trials / Completed
CompletedNCT00524355
Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD
Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of the Gastroesophageal Reflux Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,717 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To describe the frequency, type and severity of the symptoms in patients visiting the GI or internal physicians, with symptoms consistent with gastroesophageal reflux disease (GERD)
Conditions
Timeline
- Start date
- 2007-03-01
- Completion
- 2007-11-01
- First posted
- 2007-09-03
- Last updated
- 2009-07-17
Locations
2 sites across 1 country: Vietnam
Source: ClinicalTrials.gov record NCT00524355. Inclusion in this directory is not an endorsement.